Oncology Research2025，Vol.33Issue(3)：P.617-630,14.DOI:10.32604/or.2024.049772
A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma
KE TIAN 1ZHIPENG LI 2XIANGYU ZHAI 3HUAXIN ZHOU 2HUI YAO1
作者信息
- 1. General Surgery Department 2,The No.2 People’s Hospital of Lanzhou,Lanzhou,730030,China
- 2. The Hepatobiliary Surgery Department,The Second Hospital of Shandong University,Jinan,250000,China
- 3. The Hepatobiliary Surgery Department,The Second Hospital of Shandong University,Jinan,250000,China Organ Transplant Department,Qilu Hospital of Shandong University,Jinan,250000,China
- 折叠
摘要
关键词
Cuproptosis/Hepatocellular carcinoma(HCC)/Copper homeostasis/Prognostic model/Immunocytes分类
医药卫生引用本文复制引用
KE TIAN,ZHIPENG LI,XIANGYU ZHAI,HUAXIN ZHOU,HUI YAO..A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma[J].Oncology Research,2025,33(3):P.617-630,14.
